findmyKOL
Clinical trialNCT01897883CompletedObservational

Dyslipidemia Management in Chinese Post Stroke Patients

SponsorAstraZenecaEnrollment5,000Brain Ischemia,Stoke
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Yong Jun Wang

    Capital Medical University afffiliated Beijing Tiantan Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Research Site

    Beijing, Beijing Municipality, China

  • Research Site

    Guangzhou, Guangdong, China

  • Research Site

    Shenzhen, Guangdong, China

  • Research Site

    Haerbin, Heilongjiang, China

  • Research Site

    Zhengzhou, Henan, China

  • Research Site

    Zhenzhou, Henan, China

  • Research Site

    Wuhan, Hubei, China

  • Research Site

    Changsha, Hunan, China

  • Research Site

    Nanjing, Jiangsu, China

  • Research Site

    Suzhou, Jiangsu, China

  • Research Site

    Changchun, Jilin, China

  • Research Site

    Shenyang, Liaoning, China

  • Research Site

    Jinan, Shandong, China

  • Research Site

    Qingdao, Shandong, China

  • Research Site

    Shanghai, Shanghai Municipality, China

  • Research Site

    Xi’an, Shanxi, China

  • Research Site

    Chengdu, Sichuan, China

  • Research Site

    Chongqing, Sichuan, China

  • Research Site

    Tianjin, Tianjin Municipality, China

  • Research Site

    Hangzhou, Zhejiang, China

  • Research Site

    Ruian, Zhejiang, China

  • Research Site

    Taizhou, Zhejiang, China

  • Research Site

    Wenzhou, Zhejiang, China

  • Research Site

    Beijing, China

  • Research Site

    Guangzhou, China

  • Research Site

    Shanghai, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2013
Primary completion
31 Aug 2014
Completion
31 Aug 2014
Last update posted
30 Jul 2015
Registered enrollment
5,000
Registry id
NCT01897883

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.